Talk:Rasagiline

comment1
Corrected introduction to be in accordance with ref. 1, which says that trials to determine whether rasagiline is MAO-B selective have NOT YET been conducted. 208.102.122.87 (talk) 02:27, 22 January 2008 (UTC)

This article is biased and appears to be written by the manufacturer
Aziltec (Rasagiline) is an MAO inhibitor. Pharmacists in the USA who see this drug being prescribed will immediately check for contraindications of MAO inhibitors with other drugs and that is a very long list. Aziltec is one of the few remaining MAO inhibitors still in use. The "Safety" section of this article should be expanded. Heaven forbid someone take Aziltec with a serotonin reuptake inhibitor like Paxil or Klonopin. Frank Layden (talk) 00:21, 12 December 2013 (UTC)
 * Yes it did suck. I just worked it over. Jytdog (talk) 05:48, 7 February 2016 (UTC)

Is this really an MAO-B?
The study provided showing that this is an MAO-B was written by the manufacturer.

"and appears to be especially useful in dealing with non-motor symptoms like fatigue" that doesn't seem right

"Side effects when the drug is taken alone include flu-like symptoms, joint pain, depression, stomach upset, headache, dizziness, and insomnia" this sounds a lot like the effects of serotonin

Also look at the molecular structure it's literally shaped like a serotonin molecule

Whereas selegiline which definitely is a dopaminergic drug is shaped like a dopamine molecule.

Something doesn't seem quite right with this medication. JoeC46 (talk) 13:03, 11 May 2023 (UTC)